Published in Mol Pharmacol on April 01, 1992
20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels. PLoS One (2013) 0.87
Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br J Pharmacol (1995) 0.82
Altered reactivity of resistance vasculature contributes to hypertension in elastin insufficiency. Am J Physiol Heart Circ Physiol (2014) 0.79
Impact of cell type and epitope tagging on heterologous expression of G protein-coupled receptor: a systematic study on angiotensin type II receptor. PLoS One (2012) 0.76
A General Method for Nucleophilic Aromatic Substitution of Aryl Fluorides and Chlorides with Dimethylamine using Hydroxide-Assisted Decomposition of N,N-Dimethylforamide. Synth Commun (2016) 0.75
Spatial control of actin polymerization during neutrophil chemotaxis. Nat Cell Biol (1999) 3.45
Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol (2000) 2.59
Intracellular receptors for inositol 1,4,5-trisphosphate in angiotensin II target tissues. J Biol Chem (1987) 2.24
Multiple pathways of inositol polyphosphate metabolism in angiotensin-stimulated adrenal glomerulosa cells. J Biol Chem (1988) 1.50
Binding sites for inositol trisphosphate in the bovine adrenal cortex. Biochem Biophys Res Commun (1985) 1.48
Metabolism of inositol 1,3,4-trisphosphate to a new tetrakisphosphate isomer in angiotensin-stimulated adrenal glomerulosa cells. J Biol Chem (1987) 1.38
[SAF--an alternative fixation solution for parasitological stool specimens]. Schweiz Med Wochenschr (1990) 1.34
Angiotensin-stimulated production of inositol trisphosphate isomers and rapid metabolism through inositol 4-monophosphate in adrenal glomerulosa cells. Proc Natl Acad Sci U S A (1986) 1.28
Receptors for substance P. I. The pharmacological preparations. Eur J Pharmacol (1984) 1.24
A method for demonstrating gene essentiality in Staphylococcus aureus. Plasmid (2000) 1.23
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol Pharmacol (1996) 1.21
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res (2002) 1.19
Role of N-glycosylation in the expression and functional properties of human AT1 receptor. Biochemistry (1999) 1.11
The sensitivity and specificity of two methods for detecting Fasciola infections in cattle. Vet Parasitol (1999) 1.02
The epidemiology of nematode and fluke infections in cattle in the Red River Delta in Vietnam. Vet Parasitol (2000) 1.00
Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. Am J Physiol Lung Cell Mol Physiol (2001) 0.99
Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Res (1990) 0.97
Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. Biochemistry (1983) 0.96
Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy. Endocrinology (1997) 0.96
Caloxin: a novel plasma membrane Ca2+ pump inhibitor. Am J Physiol Cell Physiol (2001) 0.93
High yield photoaffinity labeling of angiotensin II receptors. Mol Pharmacol (1986) 0.91
Adrenocorticotropin receptors in rat adrenal glomerulosa cells. Endocrinology (1985) 0.91
Angiotensin II and guanine nucleotides stimulate formation of inositol 1,4,5-trisphosphate and its metabolites in permeabilized adrenal glomerulosa cells. J Biol Chem (1988) 0.91
Substance P antagonists active in vitro and in vivo. Eur J Pharmacol (1982) 0.90
The high affinity state of inositol 1,4,5-trisphosphate receptor is a functional state. J Biol Chem (1993) 0.90
Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure. Biochemistry (2000) 0.89
Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II. Mol Endocrinol (1999) 0.89
Angiotensin-induced formation and metabolism of inositol polyphosphates in bovine adrenal glomerulosa cells. Biochem Biophys Res Commun (1987) 0.89
Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. Eur J Pharmacol (1984) 0.88
The acceptability, efficacy and safety of quinacrine non-surgical sterilization (QS), tubectomy and vasectomy in 5 provinces in the Red River Delta, Vietnam: a follow-up of 15,190 cases. Int J Gynaecol Obstet (2003) 0.88
Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation. Circ Res (2000) 0.88
Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. J Gen Virol (2005) 0.87
The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. Biochem J (1989) 0.87
Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem (1994) 0.87
Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res (1988) 0.86
Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm Res (1998) 0.86
Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties. J Med Chem (1985) 0.85
Functional effects of caloxin 1c2, a novel engineered selective inhibitor of plasma membrane Ca(2+)-pump isoform 4, on coronary artery. J Cell Mol Med (2008) 0.85
Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophys Res Commun (1992) 0.85
Thiol-reactive agents biphasically regulate inositol 1,4,5-trisphosphate binding and Ca(2+) release activities in bovine adrenal cortex microsomes. Endocrinology (2001) 0.85
Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. Eur J Pharmacol (1985) 0.85
Substance P--structure-activity studies and the development of antagonists. Pharmacology (1984) 0.85
Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ Res (1999) 0.85
Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. Br J Pharmacol (2001) 0.85
The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol Pharmacol (1994) 0.85
Metabolism of inositol-1,3,4,6-tetrakisphosphate to inositol pentakisphosphate in adrenal glomerulosa cells. Biochem Biophys Res Commun (1988) 0.84
p-Nitrophenylalanine, p-azidophenylalanine, m-azidophenylalanine, and o-nitro-p-azido-phenylalanine as photoaffinity labels. FEBS Lett (1974) 0.84
Identification of angiotensin II-binding domains in the rat AT2 receptor with photolabile angiotensin analogs. J Biol Chem (1997) 0.84
Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells. Biochem J (1996) 0.84
beta 2-Inhibin contains the active core of human seminal plasma beta-inhibin: synthesis and bioactivity. FEBS Lett (1985) 0.83
Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis. J Biol Chem (1996) 0.83
Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats. J Cardiovasc Pharmacol (2000) 0.83
Angiotensin-induced changes in the apparent size of rat liver angiotensin receptors. J Recept Res (1984) 0.82
Angiotensin II receptors and mechanisms of action in adrenal glomerulosa cells. J Steroid Biochem (1987) 0.82
Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain. J Med Chem (1984) 0.82
Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue. Mol Pharmacol (1994) 0.82
Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation. Pharm Res (1997) 0.81
FK506 blocks intracellular Ca2+ oscillations in bovine adrenal glomerulosa cells. Biochemistry (2001) 0.81
The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2. Regul Pept (1993) 0.81
gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proc Natl Acad Sci U S A (1990) 0.81
Epitope tagging and immunoreactivity of the human angiotensin II type 1 receptor. Can J Physiol Pharmacol (1997) 0.81
Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes. Eur J Pharmacol (1993) 0.81
Receptors for substance P. III. Classification by competitive antagonists. Eur J Pharmacol (1984) 0.81
Inhibition of angiotensinogen production by angiotensin II analogues in human hepatoma cell line. Am J Physiol (1989) 0.81
Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state. Endocrinology (1994) 0.80
Substance P antagonists showing some selectivity for different receptor types. Eur J Pharmacol (1985) 0.80
The hydra head activator in human blood circulation. Degradation of the synthetic peptide by plasma angiotensin-converting enzyme. FEBS Lett (1984) 0.80
Direct covalent attachment of small peptide antigens to enzyme-linked immunosorbent assay plates using radiation and carbodiimide activation. Anal Biochem (1994) 0.80
125I-Tyr,D-Arg[Hyp3,D-Phe7,Leu8]BK, a radiolabelled B2 antagonist specifically interacts with two distinct binding sites on epithelial membranes of guinea pig ileum. Agents Actions Suppl (1992) 0.80
Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium. Mol Pharmacol (1993) 0.80
Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors. Br J Pharmacol (2000) 0.80
Anti-substance P anti-idiotypic antibodies. Characterization and biological activities. J Biol Chem (1985) 0.79
Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum. Eur J Pharmacol (1992) 0.79
An angiotensin II antagonist with strongly prolonged action. Biochem Biophys Res Commun (1989) 0.79
Monitoring of phospholipase A2 activation in cultured cells using tritiated arachidonic acid. Methods Mol Biol (1998) 0.79
Structure-activity studies on the C-terminal amide of substance P. J Med Chem (1982) 0.79
Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II. Receptors Channels (1998) 0.79
Partial agonists and antagonists for substance P. Eur J Pharmacol (1983) 0.79
The rate of ectopic pregnancy for 24,589 quinacrine sterilization (QS) users compared to users of other methods and no method in 4 provinces in Vietnam, 1994-1996. Int J Gynaecol Obstet (2003) 0.79
Desensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells. Endocrinology (1997) 0.79
Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology (1998) 0.79
Photoaffinity labelling of atrial natriuretic factor (ANF)-R1 receptor by underivatized 125I-ANF. Involvement of lipid peroxidation. Biochem J (1990) 0.78